Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

 

Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
M

Cleveland Clinic Expert BC Discussion: Commercial CTC Assays, ILD, Role of Lapatinib and Margetuximab, RT After Neoadjuvant ET for DCIS, Survival With Mastectomy vs. Conventional Surgery

By Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia FEATURING Megan Miller, Erin Roesch, Jame Abraham
By Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia FEATURING Megan Miller, Erin Roesch, Jame Abraham
0 views
March 8, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

03:38
Lilly Medical Affairs

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri
2021
13:53
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

Cleveland Clinic Expert BC Discussion: Commercial CTC Assays, ILD, R…

Feat. M. Miller, E. Roesch, J. Abraham
12:48
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

Prognostic Models & Biomarker Evaluation in mBC: Does Sacituzuma…

Feat. E. Roesch
15:48
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Ac…

Feat. E. Roesch
28:52
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

Cleveland Clinic Updates on BC Surgery: How to Refine Axilla Managem…

Feat. M. Miller
09:00
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

Overview of Available Treatment Options in HER2+ MBC: Tucatinib Comb…

Feat. J. Abraham
14:19
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

2021 Update on HER2+ MBC: Neratinib/Cape vs. Lapatinib/Cape in MBC, …

Feat. J. Abraham
17:28
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

Cleveland Clinic Expert Discussion on BC: Chemo Benefit With Ovarian…

Feat. J. Martin, H. Moore, E. Harris, M. Kruse
24:29
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

Cleveland Clinic Updates on IO in mTNBC: Should We Use Atezo With Pa…

Feat. M. Kruse
08:07
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

Cleveland Clinic Updates on IO in Early Stage TNBC: Will pCR Increas…

Feat. M. Kruse
21:39
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

Cleveland Clinic 2021 BC RT Updates: WBRT vs. APBI, 1-Week vs. 3-Wee…

Feat. E. Harris
12:24
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

Breast Cancer Screening and Prevention: Anastrozole vs. Tamoxifen fo…

Feat. H. Moore
10:34
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

BC Survivorship Updates: Diabetes Risk Reduction Diet & Survival…

Feat. H. Moore
08:36
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

2021 RxPONDER Study Update on Early HR+/N+ BC: How Does Chemo Affect…

Feat. J. Martin
06:12
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

8-Year Follow-Up on MINDACT Trial for Adjuvant Chemo in HR+/HER2- BC…

Feat. J. Martin
09:22
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

2021 Update on ET in BC: Palbociclib+ET in HR+/HER2- Normal Disease …

Feat. J. Martin